Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-11
1992-11-24
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
051661608
ABSTRACT:
The present invention is concerned with the compound of formula (I) ##STR1## and its acid addition salts. The invention is also directed to the use of the compound of formula (I) and its pharmaceutically acceptable acid addition salts as positive conotropic agents in mammals.
REFERENCES:
patent: 4329347 (1982-05-01), Muller et al.
patent: 4415572 (1983-11-01), Tominaga et al.
patent: 4710507 (1987-12-01), Campbell et al.
patent: 4728653 (1988-03-01), Campbell et al.
patent: 4740513 (1988-04-01), Campbell et al.
patent: 4937248 (1990-06-01), Phillips
Kauffman, et al., Chemische Bericht, vol. 99, 1966, pp. 1837 to 1842.
Kauffman et al., Chem. Abs. vol. 65, entry #7138f (1966).
Ishikawa et al., Chem. Abs. vol. 73, entry 66451n (1970).
Chem. Abstracts, vol. 61, 3067-3069, Preparation of 2- and 4- substituted quinolines from 1-(2-quinolyl)pyridinium salts. Masatomo Hamana and Kuzuhisa Funakoshi, (1964).
CA, 55, 18128C, Improvement of Bleaching Properties, etc., Molinsy Poigarnau et al., (1961).
CA, 47, 5704(i), Charles Wheelock (1953).
Bond Robert T.
Brown Donald
Burroughs Wellcome Co.
Green Hannah O.
Nielsen Larry A.
LandOfFree
Quinoline compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921827